Biotech Funding Trends and the Rise of Digital Twinning with CEO Scott Ogle
BioTalk Unzipped21 Okt 2024

Biotech Funding Trends and the Rise of Digital Twinning with CEO Scott Ogle

EP-23. In the second half of this compelling conversation on BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe continue their deep dive with Scott Ogle, CEO of TruLab. They explore the surprising parallels between the banking and pharma industries, the game-changing role of digital twinning in clinical trials, and the biotech funding landscape. Scott also shares his thoughts on leadership, mentorship, and the impact of the Inflation Reduction Act on pharma innovation. This episode offers listeners valuable insights into the future of drug development and the challenges of balancing professional and personal life in a fast-paced industry.


Chapters

1:09 - Comparison of the Banking Industry to the Pharma Industry

5:18 - Data Integrity, Same For Decentralized Trials?

8:33 - Biotech Funding Trends

11:18 - NEW NEWS! – Digital Twinning in Clinical Trials

16:15 - What Advice Would You Give to Your Younger Self?

20:57 - Mentorship and Its Impact, How it Shaped Scott

23:45 - Balancing Work and Personal Life

24:32 - The Inflation Reduction Act and Innovation


Takeaways

  • The regulatory environment in pharma can slow down innovation.

  • Digital twinning in clinical trials could revolutionize drug development.

  • Family influences play a significant role in shaping business perspectives.

  • The need for a strong company culture to maintain values during growth.

  • Biotech funding trends are influenced by macroeconomic factors like interest rates.

  • The importance of mentorship in professional development.



Sound Bites

  • “The similarities between the banking industry and the pharma industry is eerily similar.”

  • “Quality is really what we do.”

  • “Being quality is core to software.”

  • “It’s really clear people care more about their money than they do their healthcare.”

  • “Biotech and large pharma seem to balance each other out.”

  • “The career for you is at the intersection of what you are good at and what you like to do.”

  • “If you’re good at something and you like to do it, it fuels your energy to keep getting better.”

  • “Enjoy the impact in what you’re doing and accomplishing!”


New News Story:


How to reach us:

Scott Ogle

https://www.linkedin.com/in/scott-ogle/

TruLab - https://trulab.com/

Dr. Chad Briscoe

https://www.linkedin.com/in/chadbriscoe/

Celerion - https://www.celerion.com/

Gregory Austin

https://www.linkedin.com/in/gregoryaustin1/

ECI - https://eci-rx.com /

Image Credits

Digital Twinning - Credit Getty Images

Simulation - Credit: andrush / Adobe Stock

Tomáš Helikar - https://www.linkedin.com/in/tomashelikar/

Nebraska Swan computer - https://newsroom.unl.edu/announce/cse/16380/90600

Brian Hamilton - https://inmatestoentrepreneurs.org/board/brian-hamilton/

Avsnitt(41)

Transforming Immunology: The Promise of Digital Twins with Dr. Tomáš Helikar

Transforming Immunology: The Promise of Digital Twins with Dr. Tomáš Helikar

Dr. Tomas Helikar, a leading researcher in bioinformatics and systems biology, delves into groundbreaking work on developing a personalized immune digital twin, which aims to revolutionize the underst...

2 Dec 202432min

How AI is Transforming Drug Development: Reflections from AAPS - PharmSci 360 with Dr. Mark Arnold

How AI is Transforming Drug Development: Reflections from AAPS - PharmSci 360 with Dr. Mark Arnold

Dr. Mark Arnold, a distinguished bioanalytical thought leader with an impressive track record in supporting drug development programs. Mark is the Owner and Principal at Bioanalytical Solution Integra...

18 Nov 202436min

Technology Meets Purpose: Transforming Clinical Trials at TruLab with CEO Scott Ogle

Technology Meets Purpose: Transforming Clinical Trials at TruLab with CEO Scott Ogle

Summary In this 22nd episode of BioTalk Unzipped, host Gregory Austin and co-host Chad Briscoe engage with Scott Ogle, CEO of TrueLab, discussing his journey from finance to the pharmaceutical industr...

1 Okt 202433min

Mentoring in Pharmaceutical Science with Dr. Jim Shen

Mentoring in Pharmaceutical Science with Dr. Jim Shen

Mentoring in Pharmaceutical Science with Dr. Jim Shen Summary In Episode 21 of BioTalk Unzipped, host Gregory Austin and co-host Dr. Chad Briscoe interview Dr. Jim Shen, the executive director and hea...

29 Sep 202435min

Great Advances in Cancer Research with Dr. Jim Shen

Great Advances in Cancer Research with Dr. Jim Shen

In this episode (EP20) of BioTalk Unzipped, host Gregory Austin and co-host Dr. Chad Briscoe interview Dr. Jim Shen, the Executive Director and Head of Regulated Bioanalysis Operations at BMS. They di...

1 Sep 202437min

The Future of Hybrid Healthcare: Insights from Zealic CEO Chuck Piccirillo

The Future of Hybrid Healthcare: Insights from Zealic CEO Chuck Piccirillo

In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe continue their conversation with Zealic CEO, Chuck Piccirillo. They delve into the unique challenges of the patient journey and...

15 Aug 202439min

Genetic Diagnostics & Student CEOs with Dr. Jonathon Hill

Genetic Diagnostics & Student CEOs with Dr. Jonathon Hill

Summary In this conversation, Dr. Jonathon Hill discusses the unique partnership between his lab and the university, which allows students to become entrepreneurs, develop their own projects, and beco...

4 Aug 202433min

Populärt inom Business & ekonomi

framgangspodden
badfluence
varvet
rss-jossan-nina
rss-borsens-finest
rss-svart-marknad
uppgang-och-fall
rss-dagen-med-di
rss-inga-dumma-fragor-om-pengar
lastbilspodden
fill-or-kill
borsmorgon
avanzapodden
bilar-med-sladd
tabberaset
bathina-en-podcast
rss-veckans-trade
kvalitetsaktiepodden
rss-kort-lang-analyspodden-fran-di
svd-tech-brief